Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Production, Demand and Key Producers, 2022-2028

November 2022 | 97 pages | ID: G47A1E612288EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Bruton's Tyrosine Kinase Inhibitors (BTKi), Bruton's TKI or BTKI, Ibrutinib, has shown great promise for B cell cancers with the unfortunate side effect of increased incidence of atrial fibrillation. Bruton's tyrosine kinase (BTK) inhibitors work by binding to the BTK protein. BTK inhibitors block this protein's activity by the BCR-induced BTK activation and its downstream signalling. BTK inhibitors block the activity that leads to growth of the B-cells and this causes cell death of the malignant B-cells.

This report studies the global Bruton's Tyrosine Kinase (BTKi) Inhibitors production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Bruton's Tyrosine Kinase (BTKi) Inhibitors, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Bruton's Tyrosine Kinase (BTKi) Inhibitors that contribute to its increasing demand across many markets.

The global Bruton's Tyrosine Kinase (BTKi) Inhibitors market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global Bruton's Tyrosine Kinase (BTKi) Inhibitors total production and demand, 2017-2028, (K Units)

Global Bruton's Tyrosine Kinase (BTKi) Inhibitors total production value, 2017-2028, (USD Million)

Global Bruton's Tyrosine Kinase (BTKi) Inhibitors production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)

Global Bruton's Tyrosine Kinase (BTKi) Inhibitors consumption by region & country, CAGR, 2017-2028 & (K Units)

U.S. VS China: Bruton's Tyrosine Kinase (BTKi) Inhibitors domestic production, consumption, key domestic manufacturers and share

Global Bruton's Tyrosine Kinase (BTKi) Inhibitors production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)

Global Bruton's Tyrosine Kinase (BTKi) Inhibitors production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)

Global Bruton's Tyrosine Kinase (BTKi) Inhibitors production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)

This reports profiles key players in the global Bruton's Tyrosine Kinase (BTKi) Inhibitors market based on the following parameters – headquarters, production locations, products portfolio, Bruton's Tyrosine Kinase (BTKi) Inhibitors revenue, sales, average price and gross margin, recent developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Bruton's Tyrosine Kinase (BTKi) Inhibitors market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market, Segmentation by Type
  • 1st Line Treatment
  • 2nd Line Treatment
  • 3rd Line and Above Treatment
Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market, Segmentation by Application
  • Chronic Lymphocytic Leukemia
  • Follicular Lymphoma
  • Mantle Cell Lymphoma
  • Marginal Zone Lymphoma
  • Small Lymphocytic Lymphoma
  • Waldenstrom Macroglobulinemia
  • B Cell Malignancies
  • Chronic Graft-Versus-Host Disease
  • Others
Companies Profiled:
  • Johnson & Johnson
  • AbbVie
  • AstraZeneca
  • BeiGene
  • InnoCare
  • Ono Pharmaceutical
Key Questions Answered

1. How big is the global Bruton's Tyrosine Kinase (BTKi) Inhibitors market?

2. What is the demand of the global Bruton's Tyrosine Kinase (BTKi) Inhibitors market?

3. What is the year over year growth of the global Bruton's Tyrosine Kinase (BTKi) Inhibitors market?

4. What is the production and production value of the global Bruton's Tyrosine Kinase (BTKi) Inhibitors market?

5. Who are the key producers in the global Bruton's Tyrosine Kinase (BTKi) Inhibitors market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Bruton's Tyrosine Kinase (BTKi) Inhibitors Introduction
1.2 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Supply & Forecast
  1.2.1 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value (2017 & 2021 & 2028)
  1.2.2 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production (2017-2028)
  1.2.3 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Pricing Trends (2017-2028)
1.3 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production by Region
  1.3.1 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Region (2017-2028)
  1.3.2 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production by Region (2017-2028)
  1.3.3 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Average Price by Region (2017-2028)
  1.3.4 North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Production (2017-2028)
  1.3.5 Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Production (2017-2028)
  1.3.6 China Bruton's Tyrosine Kinase (BTKi) Inhibitors Production (2017-2028)
  1.3.7 Japan Bruton's Tyrosine Kinase (BTKi) Inhibitors Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Bruton's Tyrosine Kinase (BTKi) Inhibitors Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Demand (2017-2028)
2.2 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption by Region
  2.2.1 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption by Region (2017-2022)
  2.2.2 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption Forecast by Region (2023-2028)
2.3 United States Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption (2017-2028)
2.4 China Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption (2017-2028)
2.5 Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption (2017-2028)
2.6 Japan Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption (2017-2028)
2.7 South Korea Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption (2017-2028)
2.8 ASEAN Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption (2017-2028)
2.9 India Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption (2017-2028)

3 WORLD BRUTON'S TYROSINE KINASE (BTKI) INHIBITORS MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Manufacturer (2017-2022)
3.2 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production by Manufacturer (2017-2022)
3.3 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Average Price by Manufacturer (2017-2022)
3.4 Bruton's Tyrosine Kinase (BTKi) Inhibitors Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Bruton's Tyrosine Kinase (BTKi) Inhibitors in 2021
  3.5.3 Global Concentration Ratios (CR8) for Bruton's Tyrosine Kinase (BTKi) Inhibitors in 2021
3.6 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market: Overall Company Footprint Analysis
  3.6.1 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market: Region Footprint
  3.6.2 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market: Company Product Type Footprint
  3.6.3 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value Comparison
  4.1.1 United States VS China: Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value Comparison (2017 & 2021 & 2028)
  4.1.2 United States VS China: Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Comparison
  4.2.1 United States VS China: Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Comparison (2017 & 2021 & 2028)
  4.2.2 United States VS China: Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption Comparison
  4.3.1 United States VS China: Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption Comparison (2017 & 2021 & 2028)
  4.3.2 United States VS China: Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Bruton's Tyrosine Kinase (BTKi) Inhibitors Key Producers and Market Share, 2017-2022
  4.4.1 Major Manufacturer of Bruton's Tyrosine Kinase (BTKi) Inhibitors in United States, Company Headquarters and Production Place (States, Country)
  4.4.2 United States Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
  4.4.3 United States Bruton's Tyrosine Kinase (BTKi) Inhibitors Production by Domestic Manufacturer, (2017-2022)
4.5 China Bruton's Tyrosine Kinase (BTKi) Inhibitors Key Producers and Market Share, 2017-2022
  4.5.1 Major Manufacturer of Bruton's Tyrosine Kinase (BTKi) Inhibitors in China, Company Headquarters and Production Place (Province, Country)
  4.5.2 China Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
  4.5.3 China Bruton's Tyrosine Kinase (BTKi) Inhibitors Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Bruton's Tyrosine Kinase (BTKi) Inhibitors Key Producers and Market Share, 2017-2022
  4.6.1 Major Manufacturer of Bruton's Tyrosine Kinase (BTKi) Inhibitors in Rest of World, Company Headquarters and Production Place (State, Country)
  4.6.2 Rest of World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
  4.6.3 Rest of World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production by Domestic Manufacturer, (2017-2022)

5 MARKET ANALYSIS BY TYPE

5.1 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
  5.2.1 1st Line Treatment
  5.2.2 2nd Line Treatment
  5.2.3 3rd Line and Above Treatment
5.3 Market Segment by Type
  5.3.1 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production by Type (2017-2028)
  5.3.2 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Type (2017-2028)
  5.3.3 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Average Price by Type (2017-2028)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
  6.2.1 Chronic Lymphocytic Leukemia
  6.2.2 Follicular Lymphoma
  6.2.3 Mantle Cell Lymphoma
  6.2.4 Marginal Zone Lymphoma
  6.2.5 Small Lymphocytic Lymphoma
  6.2.6 Waldenstrom Macroglobulinemia
  6.2.7 B Cell Malignancies
  6.2.8 Chronic Graft-Versus-Host Disease
  6.2.9 Others
6.3 Market Segment by Application
  6.3.1 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production by Application (2017-2028)
  6.3.2 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Application (2017-2028)
  6.3.3 World Bruton's Tyrosine Kinase (BTKi) Inhibitors Average Price by Application (2017-2028)

7 COMPANY PROFILES

7.1 Johnson & Johnson
  7.1.1 Johnson & Johnson Details
  7.1.2 Johnson & Johnson Major Business
  7.1.3 Johnson & Johnson Bruton's Tyrosine Kinase (BTKi) Inhibitors Product and Services
  7.1.4 Johnson & Johnson Bruton's Tyrosine Kinase (BTKi) Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.1.5 Johnson & Johnson Recent Developments/Updates
  7.1.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.2 AbbVie
  7.2.1 AbbVie Details
  7.2.2 AbbVie Major Business
  7.2.3 AbbVie Bruton's Tyrosine Kinase (BTKi) Inhibitors Product and Services
  7.2.4 AbbVie Bruton's Tyrosine Kinase (BTKi) Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.2.5 AbbVie Recent Developments/Updates
  7.2.6 AbbVie Competitive Strengths & Weaknesses
7.3 AstraZeneca
  7.3.1 AstraZeneca Details
  7.3.2 AstraZeneca Major Business
  7.3.3 AstraZeneca Bruton's Tyrosine Kinase (BTKi) Inhibitors Product and Services
  7.3.4 AstraZeneca Bruton's Tyrosine Kinase (BTKi) Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.3.5 AstraZeneca Recent Developments/Updates
  7.3.6 AstraZeneca Competitive Strengths & Weaknesses
7.4 BeiGene
  7.4.1 BeiGene Details
  7.4.2 BeiGene Major Business
  7.4.3 BeiGene Bruton's Tyrosine Kinase (BTKi) Inhibitors Product and Services
  7.4.4 BeiGene Bruton's Tyrosine Kinase (BTKi) Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.4.5 BeiGene Recent Developments/Updates
  7.4.6 BeiGene Competitive Strengths & Weaknesses
7.5 InnoCare
  7.5.1 InnoCare Details
  7.5.2 InnoCare Major Business
  7.5.3 InnoCare Bruton's Tyrosine Kinase (BTKi) Inhibitors Product and Services
  7.5.4 InnoCare Bruton's Tyrosine Kinase (BTKi) Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.5.5 InnoCare Recent Developments/Updates
  7.5.6 InnoCare Competitive Strengths & Weaknesses
7.6 Ono Pharmaceutical
  7.6.1 Ono Pharmaceutical Details
  7.6.2 Ono Pharmaceutical Major Business
  7.6.3 Ono Pharmaceutical Bruton's Tyrosine Kinase (BTKi) Inhibitors Product and Services
  7.6.4 Ono Pharmaceutical Bruton's Tyrosine Kinase (BTKi) Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.6.5 Ono Pharmaceutical Recent Developments/Updates
  7.6.6 Ono Pharmaceutical Competitive Strengths & Weaknesses

8 RAW MATERIAL AND INDUSTRY CHAIN

8.1 Raw Material of Bruton's Tyrosine Kinase (BTKi) Inhibitors and Key Manufacturers
8.2 Bruton's Tyrosine Kinase (BTKi) Inhibitors Manufacturing Costs
8.3 Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Process
8.4 Bruton's Tyrosine Kinase (BTKi) Inhibitors Industrial Chain

9 DISTRIBUTION CHANNEL ANALYSIS

9.1 Distribution Channel Breakdown for Bruton's Tyrosine Kinase (BTKi) Inhibitors Shipments (%): 2017-2028
  9.1.1 Direct Channel
  9.1.2 Indirect Channel
9.2 Bruton's Tyrosine Kinase (BTKi) Inhibitors Typical Distributors
9.3 Bruton's Tyrosine Kinase (BTKi) Inhibitors Typical Customers

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer

LIST OF TABLES

Table 1. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Region (2017-2022) & (USD Million)
Table 3. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Region (2023-2028) & (USD Million)
Table 4. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value Market Share by Region (2017-2022)
Table 5. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value Market Share by Region (2023-2028)
Table 6. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production by Region (2017-2022) & (K Units)
Table 7. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production by Region (2023-2028) & (K Units)
Table 8. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Market Share by Region (2017-2022)
Table 9. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Market Share by Region (2023-2028)
Table 10. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Bruton's Tyrosine Kinase (BTKi) Inhibitors Major Market Trends
Table 13. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption by Region (2017-2022) & (K Units)
Table 15. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Bruton's Tyrosine Kinase (BTKi) Inhibitors Producers in 2021
Table 18. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Bruton's Tyrosine Kinase (BTKi) Inhibitors Producers in 2021
Table 20. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Company Evaluation Quadrant
Table 22. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Site of Key Manufacturer
Table 24. Bruton's Tyrosine Kinase (BTKi) Inhibitors Market: Company Product Type Footprint
Table 25. Bruton's Tyrosine Kinase (BTKi) Inhibitors Market: Company Product Application Footprint
Table 26. Bruton's Tyrosine Kinase (BTKi) Inhibitors Competitive Factors
Table 27. Bruton's Tyrosine Kinase (BTKi) Inhibitors New Entrant and Capacity Expansion Plans
Table 28. Bruton's Tyrosine Kinase (BTKi) Inhibitors Mergers & Acquisitions Activity
Table 29. United States VS China Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Bruton's Tyrosine Kinase (BTKi) Inhibitors in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Bruton's Tyrosine Kinase (BTKi) Inhibitors Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Bruton's Tyrosine Kinase (BTKi) Inhibitors in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Bruton's Tyrosine Kinase (BTKi) Inhibitors Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Bruton's Tyrosine Kinase (BTKi) Inhibitors in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production by Type (2017-2022) & (K Units)
Table 49. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production by Type (2023-2028) & (K Units)
Table 50. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Type (2017-2022) & (USD Million)
Table 51. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Type (2023-2028) & (USD Million)
Table 52. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production by Application (2017-2022) & (K Units)
Table 56. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production by Application (2023-2028) & (K Units)
Table 57. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Application (2017-2022) & (USD Million)
Table 58. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Application (2023-2028) & (USD Million)
Table 59. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 62. Johnson & Johnson Major Business
Table 63. Johnson & Johnson Bruton's Tyrosine Kinase (BTKi) Inhibitors Product and Services
Table 64. Johnson & Johnson Bruton's Tyrosine Kinase (BTKi) Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Johnson & Johnson Recent Developments/Updates
Table 66. Johnson & Johnson Competitive Strengths & Weaknesses
Table 67. AbbVie Basic Information, Manufacturing Base and Competitors
Table 68. AbbVie Major Business
Table 69. AbbVie Bruton's Tyrosine Kinase (BTKi) Inhibitors Product and Services
Table 70. AbbVie Bruton's Tyrosine Kinase (BTKi) Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. AbbVie Recent Developments/Updates
Table 72. AbbVie Competitive Strengths & Weaknesses
Table 73. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 74. AstraZeneca Major Business
Table 75. AstraZeneca Bruton's Tyrosine Kinase (BTKi) Inhibitors Product and Services
Table 76. AstraZeneca Bruton's Tyrosine Kinase (BTKi) Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. AstraZeneca Recent Developments/Updates
Table 78. AstraZeneca Competitive Strengths & Weaknesses
Table 79. BeiGene Basic Information, Manufacturing Base and Competitors
Table 80. BeiGene Major Business
Table 81. BeiGene Bruton's Tyrosine Kinase (BTKi) Inhibitors Product and Services
Table 82. BeiGene Bruton's Tyrosine Kinase (BTKi) Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. BeiGene Recent Developments/Updates
Table 84. BeiGene Competitive Strengths & Weaknesses
Table 85. InnoCare Basic Information, Manufacturing Base and Competitors
Table 86. InnoCare Major Business
Table 87. InnoCare Bruton's Tyrosine Kinase (BTKi) Inhibitors Product and Services
Table 88. InnoCare Bruton's Tyrosine Kinase (BTKi) Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. InnoCare Recent Developments/Updates
Table 90. Ono Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 91. Ono Pharmaceutical Major Business
Table 92. Ono Pharmaceutical Bruton's Tyrosine Kinase (BTKi) Inhibitors Product and Services
Table 93. Ono Pharmaceutical Bruton's Tyrosine Kinase (BTKi) Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 94. Bruton's Tyrosine Kinase (BTKi) Inhibitors Raw Material
Table 95. Key Manufacturers of Bruton's Tyrosine Kinase (BTKi) Inhibitors Raw Materials
Table 96. Bruton's Tyrosine Kinase (BTKi) Inhibitors Typical Distributors
Table 97. Bruton's Tyrosine Kinase (BTKi) Inhibitors Typical Customers

LIST OF FIGURES

Figure 1. Bruton's Tyrosine Kinase (BTKi) Inhibitors Picture
Figure 2. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production (2017-2028) & (K Units)
Figure 5. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Average Price (2017-2028) & (US$/Unit)
Figure 6. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value Market Share by Region (2017-2028)
Figure 7. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Market Share by Region (2017-2028)
Figure 8. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Production (2017-2028) & (K Units)
Figure 9. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Production (2017-2028) & (K Units)
Figure 10. China Bruton's Tyrosine Kinase (BTKi) Inhibitors Production (2017-2028) & (K Units)
Figure 11. Japan Bruton's Tyrosine Kinase (BTKi) Inhibitors Production (2017-2028) & (K Units)
Figure 12. Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Demand (2017-2028) & (K Units)
Figure 15. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption Market Share by Region (2017-2028)
Figure 16. United States Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption (2017-2028) & (K Units)
Figure 17. China Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption (2017-2028) & (K Units)
Figure 18. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption (2017-2028) & (K Units)
Figure 19. Japan Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption (2017-2028) & (K Units)
Figure 20. South Korea Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption (2017-2028) & (K Units)
Figure 22. India Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Bruton's Tyrosine Kinase (BTKi) Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Bruton's Tyrosine Kinase (BTKi) Inhibitors Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Bruton's Tyrosine Kinase (BTKi) Inhibitors Markets in 2021
Figure 26. United States VS China: Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Bruton's Tyrosine Kinase (BTKi) Inhibitors Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Bruton's Tyrosine Kinase (BTKi) Inhibitors in United States
Figure 30. Key Producers and Market Share of Bruton's Tyrosine Kinase (BTKi) Inhibitors in China
Figure 31. Key Producers and Market Share of Bruton's Tyrosine Kinase (BTKi) Inhibitors in Rest of World
Figure 32. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value Market Share by Type in 2021
Figure 34. 1st Line Treatment
Figure 35. 2nd Line Treatment
Figure 36. 3rd Line and Above Treatment
Figure 37. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Market Share by Type (2017-2028)
Figure 38. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value Market Share by Type (2017-2028)
Figure 39. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value Market Share by Application in 2021
Figure 42. Chronic Lymphocytic Leukemia
Figure 43. Follicular Lymphoma
Figure 44. Mantle Cell Lymphoma
Figure 45. Marginal Zone Lymphoma
Figure 46. Small Lymphocytic Lymphoma
Figure 47. Waldenstrom Macroglobulinemia
Figure 48. B Cell Malignancies
Figure 49. Chronic Graft-Versus-Host Disease
Figure 50. Others
Figure 51. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Market Share by Application (2017-2028)
Figure 52. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Value Market Share by Application (2017-2028)
Figure 53. World Bruton's Tyrosine Kinase (BTKi) Inhibitors Average Price by Application (2017-2028) & (US$/Unit)
Figure 54. Manufacturing Cost Structure Analysis of Bruton's Tyrosine Kinase (BTKi) Inhibitors in 2021
Figure 55. Manufacturing Process Analysis of Bruton's Tyrosine Kinase (BTKi) Inhibitors
Figure 56. Bruton's Tyrosine Kinase (BTKi) Inhibitors Industrial Chain
Figure 57. Distribution Channel Breakdown for Bruton's Tyrosine Kinase (BTKi) Inhibitors Shipments (%): 2017-2028
Figure 58. Direct Channel Pros & Cons
Figure 59. Indirect Channel Pros & Cons
Figure 60. Methodology
Figure 61. Research Process and Data Source


More Publications